Skip to content
Axcess News – Lifestyle
Author:
Herantis Pharma plc
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
June 25, 2026
Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096
June 2, 2026
It’s a Penalty Launches Largest‑Ever Global Campaign to Prevent Human Trafficking Ahead of the 2026 Global Soccer Tournament
May 21, 2026
Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease
May 19, 2026
DUKE CANNON AND THE JEEP® BRAND COLLABORATE TO CELEBRATE A SHARED LEGACY OF OUTDOOR ADVENTURE AND THE AMERICAN SPIRIT
May 11, 2026
KUMHO TIRE U.S.A. PLEDGES $25,000 TO TIRE INDUSTRY ASSOCIATION SCHOLARSHIP FUND
April 7, 2026
KUMHO TIRE U.S.A. DEBUTS FORMULA DRIFT 2026 DRIVER ROSTER AND ANNOUNCES THREE-YEAR SPONSORSHIP EXTENSION
April 1, 2026
It’s a Penalty Announces Global Partnerships and Star Athletes for Human Trafficking Prevention Campaign Ahead of the 2026 Global Soccer Tournament
March 24, 2026
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
March 16, 2026
Herantis Pharma releases 2H and FY 2025 report today
March 7, 2026
1
2
Next Page
→